Dillard’s, Inc. (NYSE:DDS), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in the past couple of months on the NYSE. The recent share price gains has brought the company back closer to its yearly peak. As a mid-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. However, could the stock still be trading at a relatively cheap price? Let’s take a look at Dillard’s’s outlook and value based on the most recent financial data to see if the opportunity still exists.
See our latest analysis for Dillard’s
What’s The Opportunity In Dillard’s?
Great news for investors – Dillard’s is still trading at a fairly cheap price. Our valuation model shows that the intrinsic value for the stock is $629.92, but it is currently trading at US$424 on the share market, meaning that there is still an opportunity to buy now. Another thing to keep in mind is that Dillard’s’s share price may be quite stable relative to the rest of the market, as indicated by its low beta. This means that if you believe the current share price should move towards its intrinsic value over time, a low beta could suggest it is not likely to reach that level anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range again.
What does the future of Dillard’s look like?
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company’s future expectations. However, with an extremely negative double-digit change in profit expected over the next couple of years, near-term growth is certainly not a driver of a buy decision. It seems like high uncertainty is on the cards for Dillard’s, at least in the near future.
What This Means For You
Are you a shareholder? Although DDS is currently undervalued, the adverse prospect of negative growth brings about some degree of risk. We recommend you think about whether you want to increase your portfolio exposure to DDS, or whether diversifying into another stock may be a better move for your total risk and return.
Are you a potential investor? If you’ve been keeping an eye on DDS for a while, but hesitant on making the leap, we recommend you research further into the stock. Given its current undervaluation, now is a great time to make a decision. But keep in mind the risks that come with negative growth prospects in the future.
In light of this, if you’d like to do more analysis on the company, it’s vital to be informed of the risks involved. For instance, we’ve identified 2 warning signs for Dillard’s (1 shouldn’t be ignored) you should be familiar with.
If you are no longer interested in Dillard’s, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
Valuation is complex, but we’re helping make it simple.
Find out whether Dillard’s is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
